Core Viewpoint - The Hong Kong stock market continues its strong performance, with the Hang Seng Index rising by 2.58%, driven by positive market sentiment and significant inflows into various ETFs managed by GF Fund [1]. Group 1: Market Performance - The Hong Kong stock market's strong performance is reflected in the gains of nine ETFs under GF Fund, with the Hong Kong Innovative Drug ETF (513120) rising over 4.26%, and several other ETFs, including the China Concept Internet ETF (159605) and the Hang Seng Technology ETF Leader (513380), also showing gains exceeding 3% [1]. - The AH premium index has dropped to around 125%, nearing historical lows, which is attributed to continuous inflows from southbound funds and the attractiveness of high-dividend assets in the Hong Kong market [1]. Group 2: Investment Strategies - Huatai Securities' Hong Kong stock strategy team recommends focusing on sectors with improving sentiment and low valuations, particularly emphasizing technology stocks [2]. - The team suggests increasing allocations to internet e-commerce leaders ahead of the mid-August reporting period for overseas Chinese stocks, particularly those with good valuation and improving sentiment [2]. Group 3: ETF Product Overview - GF Fund's range of nine Hong Kong ETFs covers key sectors such as technology, innovative drugs, non-bank financials, and new consumption, catering to investors' needs for capturing market trends [3]. - The Hong Kong Innovative Drug ETF (513120) is the largest in the market, with a scale exceeding 18 billion, and has delivered over 100% returns this year [2]. - The Hong Kong Non-Bank ETF (513750) has also seen significant inflows, with a scale surpassing 13.7 billion, allowing for efficient investment in quality non-bank assets [2].

Core Viewpoint - The Hong Kong stock market showed slight declines, but biotechnology stocks performed strongly, with the Hong Kong Stock Connect Technology ETF (513860) gaining over 28% year-to-date [1] Group 1: Market Performance - As of 13:06, the Hong Kong Stock Connect Technology ETF (513860) rose by 0.10%, with notable individual stock performances including Sunny Optical Technology up over 6%, BYD Electronics up over 5%, and Lion Group Holding up over 4% [1] - The Hong Kong Stock Connect Technology ETF (513860) has seen a net inflow of 270 million yuan over the last five trading days, with a total net inflow of 545 million yuan over the past three months and 686 million yuan year-to-date [1] Group 2: Share Buybacks - On July 9, 37 Hong Kong-listed companies, including Tencent Holdings, conducted share buybacks totaling 49.01 million shares and 1.129 billion HKD [1] - Tencent Holdings repurchased shares worth 500 million HKD on the same day, bringing its total buyback amount for the year to 39.543 billion HKD [1] - WuXi Biologics also repurchased shares worth 298 million HKD, with a year-to-date total of 1.708 billion HKD [1] Group 3: Market Outlook - China Galaxy Securities noted that global macro risks are rising, impacting market risk appetite, but the absolute valuation of Hong Kong stocks remains relatively low, indicating medium to long-term investment value [1] - Guoyuan Hong Kong expects potential policy measures to support Hong Kong stock valuations in the second half of the year amid weakening economic momentum due to tariff impacts [1] Group 4: ETF Composition - The Hong Kong Stock Connect Technology ETF (513860) closely tracks the CSI Hong Kong Stock Connect Technology RMB Index, with the top ten weighted stocks as of July 9, 2025, including Xiaomi Group-W, Tencent Holdings, BYD Company, Alibaba-W, Meituan-W, SMIC, Kuaishou-W, Li Auto-W, Innovent Biologics, and Xpeng Motors-W, collectively accounting for 68.47% of the index [1]